Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
Yan Zhao(Peking University), Bo Chen(Bioscience (China)), Bin Yang(Southern Medical University), Qingchun Diao(Beijing University of Chinese Medicine), Xiujuan Xia(Qingdao University), Xiaohua Tao(Zhejiang Provincial People's Hospital), Qianjin Lu(Central South University), Furen Zhang(Shandong Provincial Institute of Dermatology and Venereology), Fuqiu Li(Second Affiliated Hospital of Jilin University), Liming Wu(Hangzhou First People's Hospital), Xiao‐Yong Man(Second Affiliated Hospital of Zhejiang University), Linfeng Li(Beijing Tongren Hospital), Jianzhong Zhang(Chinese Academy of Sciences), Chunlei Zhang(Peking University), Yumei Li(Qingdao University), Jinyan Wang(Ningbo No. 2 Hospital), Hao Cheng(Sir Run Run Shaw Hospital), Yingmin Jia(Bioscience (China)), Guoqing Zhao(Jilin University), Xiaohong Zhu(Shanxi Medical University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Jianyun Lu(Central South University), Jingyi Li(Sichuan University), Jinchun Yan(Bioscience (China)), Yangfeng Ding(Shanghai Stomatological Hospital)
Cited by 40
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
|Nature Genetics|2009|951
Demethylation of <i>CD40LG</i> on the Inactive X in T Cells from Women with Lupus
|The Journal of Immunology|2007|466
Induced Regulatory T Cells: Their Development, Stability, and Applications
|Trends in Immunology|2016|451
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
|Clinical Reviews in Allergy & Immunology|2013|372